GLP-1 Drugs & Addiction: Veterans Study Reveals Hope
The burgeoning class of drugs initially designed to combat diabetes and obesity – semaglutide, tirzepatide, and others – are rapidly rewriting the landscape of metabolic health. But their influence doesn’t stop there. A groundbreaking analysis of over 600,000 veterans’ health records suggests a remarkable, and potentially paradigm-shifting, side effect: a significant reduction in the risk … Read more